According to filings with the U.S. Securities and Exchange Commission, Cortica is raising $75,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Neil Hattangadi played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Cortica
Cortica is a rapidly growing healthcare company pioneering a unique and effective approach to treating neurodevelopmental conditions including autism spectrum disorder, speech and language delays, sensory processing disorder and other conditions that impact brain development. Harnessing insights and technologies from emerging neuroscience, Cortica brings together clinical specialists from a range of disciplines to design and deliver comprehensive care to children with developmental differences. Corticas treatment model coordinates a multidisciplinary team of clinicians with the common goals of fostering the childs holistic development and empowering family members. An inside out component focuses on improving the health of the body through medical diagnosis and treatment, nutrition, supplements, neurofeedback, and other strategies. Simultaneously, an outside-in component optimizes the environment, learning opportunities, and overall experiences of the child through speech and language therapy, neurological music therapy, occupational therapy, a progressive model of Applied Behavioral Analysis, and parent education. More than simply bringing these services under one roof, specialists at Cortica collaborate to achieve a common understanding of each patient, develop individually tailored treatment plans, and coordinate care that evolves to match the childs progress.

To learn more about Cortica, visit http://www.corticacare.com/

Contact:
Neil Hattangadi, Chief Executive Officer
858-304-6440

SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.